Oncotarget: Advancing Medical Science By Quickly Publishing Scientific Breakthroughs

Breakthroughs in medical science are taking place every day that can advance cancer prevention and care and lengthen and improve the lives of millions of people. Unfortunately many of the people that need that information to heal themselves or their patients do not know where to find the information. Weekly peer-reviewed medical journal Oncotarget is working to change that. The open access publication enables physicians, scientists and researchers to quickly publish their findings after a rigorous review process. Through Oncotarget scientists working on radically different areas of cancer and aging can share information that can have a positive impact on their work.

This helps to give more people access to the groundbreaking information on ResearchGate.net the journal’s writers reveal through their papers. That matches perfectly with the publication’s goal to make the results of scientific study, research and clinical experience available to as many people as possible as quickly as possible. This enables exceptional new discoveries to begin being used to save and improve lives. Oncotarget is helping to increase the impact new medical science information has on people who need it right now.

When it first began publishing Oncotarget was focused only on news related to cancer treatment and research on oncotarget.com. As part of its mission to eliminate borders so people with different medical specialties can share biomedical findings with each other, Oncotarget now accepts papers on aging, cardiology, endocrinology, cell and molecular biology, metabolism, gerotarget, immunology, microbiology, pharmacology, neuropathology, neuroscience and more. This helps to link biomedical scientists and lead to rapid growth and application of new disease fighting basic and clinical science solutions.

The publication’s leadership are prominent scientists. Oncotarget currently has co-editors-in-chief. They are Mikhail Blagosklonny an oncologist and college professor and pre-eminent cancer researcher Andrei V. Gudkov. Their work has helped the researchers whose work they publish make measurable contributions to modern scientific progress as mankind works to eliminate disease and prolong life. The publication at http://www.scimagojr.com/journalsearch.php?q=19900191708&tip=sid recently released important information from two recent studies. One study dealt with e-cigarettes and gum tissue damage. The other was about the identification of MET amplification as a gastric cancer therapeutic target.

Oncotarget helps to make a difference in people’s lives and medical research and treatments through the rapid sharing of breaking medical science news.